Advertisement
Screener

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months

2.3 / 5 stars · 38/82 Roast Me

ADAPTIMMUNE THERAPEUTICS PLC Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months of $1.54 million as of 2022-03-31, per its 10-Q filed 2022-05-09.

Discontinued › Notes › Investments › Debt and Equity Securities

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months · last filed 2022-05-09

  • 2022-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $1.54M.
  • 2021-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $390.00K.
Period endDebt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months
2022-03-31$1.54M
10-Q · filed 2022-05-09
2021-12-31$390.00K
10-Q · filed 2022-05-09